Beacon Lakes — the Dolphin Expressway at NW 137th Avenue on Miami’s western edge, one interchange from the airport’s west cargo entrance — keeps an FDA import refusal lawyer busier than almost anywhere in America. Beacon Lakes, the sprawling business park along the Dolphin Expressway at Miami’s western edge, is built around one fact: it sits minutes from Miami International Airport’s cargo aprons. Forwarders and importers here handle time-critical air freight — produce, seafood, pharmaceuticals, device components — where a hold measured in days can destroy the value of the goods entirely. For air-cargo-driven businesses in Beacon Lakes, the difference between a same-week release and a slow-rolling detention response is often the entire margin on the shipment.
Quick answer
A refusal of admission is FDA’s final call that your shipment does not enter U.S. commerce — the goods must be exported or destroyed, generally within 90 days. The time to change the outcome is before the refusal issues, in the detention window; after it issues, the work shifts to salvaging value, protecting your import record and preventing the next one.
Why this matters now
Beyond losing the goods, an unmanaged refusal invites cascading costs — storage through the export window, CBP penalty claims, and a screening history that slows every subsequent shipment. For repeat importers, the record matters more than the load.
The rules in plain terms
Refusal is the end-stage of FDA’s admissibility process under section 801(a) of the Food, Drug, and Cosmetic Act. After a detention, if no testimony is submitted, the testimony fails, or a reconditioning attempt does not succeed, FDA issues a refusal of admission. CBP then supervises the required exportation or destruction of the merchandise, generally within 90 days.
Refusals carry consequences beyond the lost shipment. They become part of the compliance history FDA screens against — raising examination rates for future entries — and a pattern of refusals is the classic path onto an import alert. Redelivery demands and liquidated-damages claims from CBP can follow when refused goods were conditionally released and are not returned on time.
Where a refusal has not yet issued, aggressive use of the detention window — testimony, private laboratory evidence, or a reconditioning plan on FDA Form 766 — remains the best play. Where it has, options still exist: export for sale in other markets, contesting liquidated damages, and building the corrective record that keeps one refusal from becoming a standing problem.
How the process works
- Immediate triage: where the entry stands between detention, refusal and CBP redelivery, and what deadlines remain
- Where possible, a testimony or reconditioning submission aimed at heading off the refusal
- After refusal: managing supervised export or destruction to minimize cost and preserve resale value abroad
- Defense against CBP liquidated-damages claims tied to the refused entry
- Root-cause corrective actions and documentation to protect your screening profile on future entries
Serving Beacon Lakes from Brickell
The work around Beacon Lakes — international freight forwarding, perishables and produce importers, pharmaceutical logistics, medical device warehousing, export consolidation — is FDA-regulated at nearly every turn, and matters here move on the Dolphin Expressway at NW 137th Avenue on Miami’s western edge, one interchange from the airport’s west cargo entrance. Garg Law's Miami office is at 1221 Brickell Avenue, and the practice was built for exactly this market: founder Shelly Garg spent years counseling importers at the world's largest dedicated international trade law firm before opening her own, and works at the crossroads of FDA and CBP compliance for foreign and domestic companies across the food, beverage, supplement, cosmetics, OTC drug and medical device industries.
Best practices — and common mistakes
- Abandoning the goods without a compliant export or destruction, triggering CBP claims
- Missing the export window and losing salvage value entirely
- Failing to contest inflated liquidated-damages assessments
- Re-importing the same non-compliant product and building an import-alert record
- Never diagnosing why the refusal happened, so it happens again
Frequently asked questions
Can an FDA refusal of admission be appealed?
There is no formal appeal once refusal issues; the meaningful opportunity is the detention stage. In limited circumstances FDA will reconsider — for example where the refusal rests on documented error — but the practical remedies are export, destruction and protecting the next entry.
What is the deadline to export refused goods?
Generally 90 days from the refusal, under CBP supervision. Blowing the window can convert the merchandise to government custody for destruction and expose the importer and surety to liquidated damages under the entry bond.
Can refused products be sold in another country?
Often yes — a U.S. refusal is not a global ban. Export must follow CBP supervision requirements, and destination-market rules apply, but supervised export for resale is frequently the best value-recovery path.
Why did I get a liquidated-damages notice after a refusal?
If goods were conditionally released and FDA later refused them, CBP may demand redelivery; failure to redeliver on time breaches the entry bond. These claims are frequently reducible through petition — they should not simply be paid at face value.
Will one refusal put me on an import alert?
Usually not by itself — but refusals are the raw material of import-alert listings. One refusal with a documented corrective response reads very differently to FDA than one of several unexplained ones.